Health & Medicine

Researchers from Health Sciences and Engineering worked together on a targeted approach using bacteriophages to disarm harmful microbes without disrupting the broader gut ecosystem.

Research ethics boards must not become so preoccupied with the potential harm of participation that they overlook the certain harm of exclusion, write Sonia Anand, Gina Ogilvie and Vanessa Watts.

The support for startups in Ontario promises to address health-care challenges, boost the Canadian economy and improve patient care.

The discovery may explain side-effects from taking statins, opening the door to future therapies that could make statins easier to tolerate.   

Researchers have developed a strategy that simultaneously attacks deadly glioblastoma tumours as well as the immune cells they hijack to help them grow.

Canada’s aging population is a marker of national success, not a crisis, writes Parminder Raina. It's also an opportunity to build the strongest aging society in the world.

Maich will work with a McMaster startup which is advancing a first-in-class precision medicine to prevent secondary metastatic brain cancer.

Researchers have identified a biological pattern that helps explain why only some microbes are chemistry powerhouses - and the reason could help guide the search for urgently needed new medicines. 

The latest investment brings Labarge's total philanthropic support for McMaster to more than $62 million and strengthens one of the world's leading aging research ecosystems.

The cluster of genes produces four antibiotics that collectively work to stop multidrug-resistant bacteria, a discovery that could lead to more effective ways to fight drug-resistant infections.

With the funding from the Public Health Agency of Canada, Melissa Kimber will test a framework to help young people transitioning into adulthood from the child welfare system.

Novel drug candidates are designed to intercept rogue cancer cells before they depart other primary tumours and travel toward the brain.